Skip to main content
Drugs in Context logoLink to Drugs in Context
. 2023 Nov 1;12:2023-10-3. doi: 10.7573/dic.2023-10-3

Corrigendum: real-world management of abnormal scarring using topical silicone gel: expert consensus and case series from the Asian SCARS Expert Group

PMCID: PMC10653586  PMID: 38021408

Abstract

The authors wish to make the following corrections to their article: Yang X, Lohsiriwat V, Chang FCS, Chye TT, Howard CJ, Qiao L, Shaw SW, Tran TNA, Yung C, Dellosa D, Nagrale D. Real-world management of abnormal scarring using topical silicone gel: expert consensus and case series from the Asian SCARS Expert Group. Drugs Context. 2023;12:2023-4-3. https://doi.org/10.7573/dic.2023-4-3

Corrigendum

The authors regret that there are errors in their original paper.

The following shows where original text has been removed (strikethrough) and new wording introduced (underlined).

Page 9, Figure 9A

Figure 9.

Figure 9

Improvement in caesarean section scar in a 30-year-old woman following application of Dermatix Ultra silicone gel from 2 weeks post-surgery for 6 months (case 9).

(A) Pre- surgerytreatment; (B) 10 days post-surgery; (C) 1-month post-surgery; (D) 6 months post-surgery.


Articles from Drugs in Context are provided here courtesy of BioExcel Publishing Ltd

RESOURCES